Arcus and Summit team up to test kidney cancer drug combo
Go back to Arcus and Summit team up to test kidney cancer drug combo| (NYSE: RCUS) | Delayed: 29.51 -0.05 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.56 | 52 Week High | $ | |||
| Open | $29.23 | 52 Week Low | $ | |||
| Day High | $29.86 | P/E | N/A | |||
| Day Low | $28.94 | EPS | $ | |||
| Volume | 896,380 | |||||
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 12.82 +0.04 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.78 | 52 Week High | $19.75 | |||
| Open | $12.60 | 52 Week Low | $4.26 | |||
| Day High | $13.00 | P/E | N/A | |||
| Day Low | $12.53 | EPS | $0.00 | |||
| Volume | 4,603,174 | |||||
